ticker,published_utc,title,publisher,url
APLS,2025-11-12T16:41:36+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Presents at Stifel 2025 Healthcare Conference Transcript",SeekingAlpha,https://finnhub.io/api/news?id=0cc881eab21b98f8059de44cec90b80bfd838ef4a07ebe2c5456197e7be08c55
APLS,2025-11-06T14:45:05+00:00,"Caterpillar upgraded, Elf Beauty downgraded: Wall Street's top analyst calls",Yahoo,https://finnhub.io/api/news?id=4f79f7b06921782b89a90509adaed7c704644b35208d4c75cba38ece23afe19f
APLS,2025-11-05T12:00:00+00:00,Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference,Yahoo,https://finnhub.io/api/news?id=7ed0108dab7a459a64c7cfabdafdda26e725eb0dd29b85b342186e4d4209e139
APLS,2025-10-31T17:45:00+00:00,Apellis Stock Down Despite Q3 Earnings and Revenues Beat Estimates,Yahoo,https://finnhub.io/api/news?id=366cee1c44414170d867771e81b6802983c7bd89d0656facb4e354974e6f2163
APLS,2025-10-31T14:15:52+00:00,"Apellis Pharmaceuticals (APLS): Forecast 13% Annual Revenue Growth, Shares Trade at Deep Discount Heading Into Earnings",Yahoo,https://finnhub.io/api/news?id=5464072fec63295a7ae27c1ba7be286b64f2136bc01726ffa851863608665f18
APLS,2025-10-31T11:36:32+00:00,"Apellis Pharmaceuticals, Inc. 2025 Q3 - Results - Earnings Call Presentation",SeekingAlpha,https://finnhub.io/api/news?id=7ceb12254964a20aaca6ad4d39684b946142289daa44bcb0d534366e9039c5bb
APLS,2025-10-30T20:32:53+00:00,Apellis Pharmaceuticals Inc (APLS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...,Yahoo,https://finnhub.io/api/news?id=e157007fdc3272779c6a12ab3c63bb5fe7acc3dcda2d8091127f7ec1691f3cc4
APLS,2025-10-30T20:16:27+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Q3 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=aa382326c65dfedef52d6ffa896965e8a806becf8375bfe105cafd9e70c293cf
APLS,2025-10-30T13:30:09+00:00,Apellis Pharmaceuticals (APLS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates,Yahoo,https://finnhub.io/api/news?id=6a8ffa3dbf485e7934ede360a85fc728e164f00accd60d7957ceca7cd5b2aa0a
APLS,2025-10-30T12:15:02+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Q3 Earnings and Revenues Top Estimates",Yahoo,https://finnhub.io/api/news?id=59b8c4f3553b97b78cf1e77cef184359dfb41b2f944ec77a7638b7ea1437e978
APLS,2025-10-30T11:05:00+00:00,Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results,Yahoo,https://finnhub.io/api/news?id=c7a7dc370d95c79046ba8c9314f61817769ddfdf2a274534059dd447aef505ae
APLS,2025-10-27T14:00:13+00:00,Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Yahoo,https://finnhub.io/api/news?id=6c8c43d76628bac9f84b0aa5a3ce3b7b5515c89f2e714058be11a64b62a0db80
APLS,2025-10-24T10:13:30+00:00,Why Apellis Pharmaceuticals (APLS) Could Gain from EMPAVELI’s Edge in Rare Kidney Disease Treatment,Yahoo,https://finnhub.io/api/news?id=68a0e3f9a5974263542a5a039545cb5008059833b58ccc3aa2b81e9ff123d650
APLS,2025-10-23T14:00:39+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Reports Next Week: Wall Street Expects Earnings Growth",Yahoo,https://finnhub.io/api/news?id=a06297e591bc90b60eef49f957de7ebc62e80438471d86d91883a08c78de2f1d
APLS,2025-10-16T11:00:00+00:00,"Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results",Yahoo,https://finnhub.io/api/news?id=d73f3c3c4e732ed2c549d5b790489fa90f287604534d2ad65a6b03d32b62f795
APLS,2025-10-15T18:57:06+00:00,"Wall Street Analysts Just Upgraded These Hot Stocks: UBER, LOGI, DASH, APLS",Yahoo,https://finnhub.io/api/news?id=afd94991533bdd1bd7ec7ef18343478b86690707c4701f67d1af2b7104d0eb0c
APLS,2025-09-30T16:34:02+00:00,"Apellis Pharmaceuticals: Maintaining ""Buy"" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders",SeekingAlpha,https://finnhub.io/api/news?id=94ffbec0f07817bb7b90e09dd6a00d2117a729e8a67c225cb8ceb0d2cfeed668
APLS,2025-09-30T08:13:01+00:00,Wall Street Has a Mixed Opinion on Apellis Pharmaceuticals (APLS),Yahoo,https://finnhub.io/api/news?id=a3b0a5bd274d7ed1975ac28d57fb23e3c67fad62591f4697adfff780d0c52919
APLS,2025-09-12T11:23:28+00:00,"When Can We Expect A Profit From Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)?",Yahoo,https://finnhub.io/api/news?id=4afb8ebde8a44e1ad46b04fc17dc1b9709d714556d2d1146380764c775b1d76b
APLS,2025-09-09T12:55:36+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Presents At Baird Global Healthcare Conference (Transcript)",SeekingAlpha,https://finnhub.io/api/news?id=2fc5d82243a45c181543fa474e6036009588ca2e02a725534b638a97d3ee828a
APLS,2025-09-04T11:20:07+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Presents At Cantor Global Healthcare Conference 2025 (Transcript)",SeekingAlpha,https://finnhub.io/api/news?id=8fd8a6c9b283a10a6aea2d3091cc4d66171d786705850f9995df690579ea4fca
APLS,2025-09-03T11:24:54+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript",SeekingAlpha,https://finnhub.io/api/news?id=06a8ae63230fa36762efcd848574193e33b34dfb6fa4d6bd38ba0ec010392c4e
APLS,2025-08-27T11:00:00+00:00,Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences,Yahoo,https://finnhub.io/api/news?id=93e8e5d33793425fd4e26e5422190421f1d95766c5e412d476968e5660df0e20
APLS,2025-08-17T10:50:30+00:00,Beam Therapeutics: A Slow-Developing Story,SeekingAlpha,https://finnhub.io/api/news?id=5669c6603a4581cb3a47182464b01980192c8fe0b301f23507140e511a6604c8
APLS,2025-08-14T12:12:05+00:00,Apellis Pharmaceuticals: Restart Of Growth Story After Empaveli's New Approval,SeekingAlpha,https://finnhub.io/api/news?id=9d9e6f6b72615dbac1b40c12b48ec208e76c4a6c8496716ec03da3cf4e3f7454
APLS,2025-08-13T05:17:08+00:00,FDA Approval and Strategic Deals Drive Apellis Pharmaceuticals’ Stock Higher for the Week,Yahoo,https://finnhub.io/api/news?id=4dba70567f90195c0554a40d83eaae67b36b2be3618606f55da4dcc042ec9489
APLS,2025-08-02T12:38:38+00:00,"Apellis Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag",Yahoo,https://finnhub.io/api/news?id=a2041ea3c2ec9abab49d04d7ccb93252224bdfe1c1215407becab5b5c2dce045
APLS,2025-08-02T04:23:45+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Q2 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=f30eb2e3d11d6e27e144bd07e8589bddb509efc372551577107341481c6cc3b6
APLS,2025-08-02T04:23:44+00:00,"Apellis Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call Presentation",SeekingAlpha,https://finnhub.io/api/news?id=2515f6ac20851190edb7a63f33fa17c9b97c1ca70cadec83f3ade35aadde3024
APLS,2025-08-01T17:23:09+00:00,Apellis Pharmaceuticals (APLS) Surges 17.6% on Higher Price Target,Yahoo,https://finnhub.io/api/news?id=2f6b6c5612998fcb36d7f78144362c287f6bf4011c37a020259eee443fce077b
APLS,2025-08-01T14:29:42+00:00,Apellis Pharmaceuticals: The Picture Becomes Clearer,SeekingAlpha,https://finnhub.io/api/news?id=1528a02f71c7b429fccdc68f23eb548cc61050b476de98b742be208e2bbba353
APLS,2025-07-31T13:30:08+00:00,Apellis Pharmaceuticals (APLS) Reports Q2 Earnings: What Key Metrics Have to Say,Yahoo,https://finnhub.io/api/news?id=c29eed63cf55315471f9f0281104a8dad099b1c90ddcad3fcc100d2c230bf0b6
APLS,2025-07-31T11:05:00+00:00,Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results,Yahoo,https://finnhub.io/api/news?id=69cc30678553a8414c5d8638e0f68825209da30a5f05aa1d97e90a3e199bb3d8
APLS,2025-07-30T12:30:00+00:00,Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval,Yahoo,https://finnhub.io/api/news?id=cc6e88c59d96802e89d8373a5ee1a7b7ff33163c7132d55ceec650591279265a
APLS,2025-07-29T12:45:01+00:00,Repligen (RGEN) Lags Q2 Earnings Estimates,Yahoo,https://finnhub.io/api/news?id=7e2347337de7f7fddbc765d3e0bd9941f1f7d556017c40b08a11241ba491603b
APLS,2025-07-28T23:19:00+00:00,FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older,Yahoo,https://finnhub.io/api/news?id=b5af2b40a2c47f041b01e8466d76f6971f3d67a68d7df07bdd1435b0039f6b5f
APLS,2025-07-28T14:00:08+00:00,Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?,Yahoo,https://finnhub.io/api/news?id=248c449c809ffa1e9b304c08df1490be005f6b3af95ec0d44c94c158808bf794
APLS,2025-07-24T11:00:00+00:00,"Apellis Pharmaceuticals to Host Conference Call on July 31, 2025, to Discuss Second Quarter 2025 Financial Results",Yahoo,https://finnhub.io/api/news?id=72de80e6517390cd0ad3e2eed8c9482700a483b2f9b3405006fbf97f3e73c1d8
APLS,2025-07-16T15:54:00+00:00,Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag,Yahoo,https://finnhub.io/api/news?id=1ca2e9fe74ae1d87186446b0215a3bcf827163d3584b73c48e39a3d6684d6d6a
APLS,2025-07-15T11:00:00+00:00,Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting,Yahoo,https://finnhub.io/api/news?id=53fafe9d1111eef3824224a0cb71caaa41c36ba1537a0e68bfae7feeb606d577
APLS,2025-07-09T04:55:09+00:00,Apellis Sells Aspaveli Ex-US Royalties to Sobi for Up to $300M,Yahoo,https://finnhub.io/api/news?id=02b2b908acd212b6d8b63e356e11e3aa6a1e29ef0f312a55d3256392e497163f
APLS,2025-07-07T17:38:05+00:00,High Growth Tech Stocks To Watch In The US July 2025,Yahoo,https://finnhub.io/api/news?id=274c2ffc7954543cc7d45f70d842cdc7fc7c0b2c0949e8731616cf46ee1a2f67
APLS,2025-07-06T08:15:52+00:00,"Morgan Stanley Raises PT on Apellis Pharmaceuticals (APLS) to $26, Keeps a Hold Rating",Yahoo,https://finnhub.io/api/news?id=ad4e280f41a2576365133e7f5f477541ed6ec8082ba7dce3178728252b1ff05d
APLS,2025-07-03T02:08:42+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Insider Activity Signals Possible Market Mispricing",Yahoo,https://finnhub.io/api/news?id=35e5b324fc1d39c239950d75b3a854c73b4ae999494dc8045628526898aec4f7
APLS,2025-07-01T11:40:00+00:00,Sobi to amend existing agreement with Apellis for ex-U.S. royalties of Aspaveli® (systemic pegcetacoplan),Yahoo,https://finnhub.io/api/news?id=476aaa1caa40a38e99a5c436c6d8a9a4075270b930a8e4aa7109dc01bcac72ca
APLS,2025-07-01T11:00:00+00:00,Apellis to Receive up to $300 Million from Royalty Purchase Agreement with Sobi for Ex-U.S. Royalties of Aspaveli® (systemic pegcetacoplan),Yahoo,https://finnhub.io/api/news?id=7ccff6e39ba9d57685fecc865c24c7f4db5781814208ab1a908b3b1c60f8f318
APLS,2025-06-20T10:07:49+00:00,Beam Therapeutics: Progress Of BEAM-101 Presses Forward With H2 2025 Data Releases,SeekingAlpha,https://finnhub.io/api/news?id=82a5837db4f997bf7342a6395c98a284614dd423fc25e150f258cb0b629c2450
APLS,2025-06-13T15:30:05+00:00,Why Is Kodiak Sciences (KOD) Up 10.5% Since Last Earnings Report?,Yahoo,https://finnhub.io/api/news?id=86e58aab5f940047cf9e401a93eda0e9128ecf8972da0d95831bb72c8fdb378b
APLS,2025-06-11T12:05:17+00:00,"Transcript : Apellis Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 10",Finnhub,https://finnhub.io/api/news?id=5fa2bd638c963f7a46462d24b0f9d46de59094cb9b1cd237dc1a777cf5d00163
APLS,2025-06-11T09:44:00+00:00,Harbor Long-Short Equity ETF Q1 2025 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=4001480176008bbf4595c2c4c1a3084a811294b5079d7afe02aca435b6e56dce
APLS,2025-06-09T09:31:07+00:00,Sobi and Apellis report new data from Phase III trial for C3G and IC-MPGN,Yahoo,https://finnhub.io/api/news?id=5b29256e9bd4b88a485edb5fd5be520ab31e19b1053eca6827226d6c926b34ec
APLS,2025-06-09T09:22:14+00:00,"Sobi and Apellis, Aspaveli, Empaveli Demonstrates Sustained One-Year Efficacy in Phase 3 Study for Rare Kidney Diseases",Finnhub,https://finnhub.io/api/news?id=67cd534169df94296f796506934b56242079df7f2591afa2e21a22859024d038
APLS,2025-06-07T13:25:18+00:00,"Apellis, Sobi present data from open-label period of Phase 3 VALIANT study",Yahoo,https://finnhub.io/api/news?id=95595c386075a109b9c04e768caafcdd6a6079508dabf71cd63d2785aa2b144a
APLS,2025-06-06T15:31:00+00:00,Why Is Apellis Pharmaceuticals (APLS) Up 7.2% Since Last Earnings Report?,Yahoo,https://finnhub.io/api/news?id=522c2141e8ae046d994d8e888a9b44929754d0de221364ada4d58dfb1472ce44
APLS,2025-06-06T13:15:00+00:00,Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN,Yahoo,https://finnhub.io/api/news?id=92f5c6dea96dd0ea6352ad1e820c49471463b631062099a76b840724a7180b50
APLS,2025-06-06T10:20:40+00:00,"Apellis Pharmaceuticals, Inc. and Sobi Announce EMPAVELI®? (Pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN",Finnhub,https://finnhub.io/api/news?id=3fe958cadb26599cff820468b29077835ab980e3afe12e922fdb4ae11fffb30a
APLS,2025-06-05T17:38:11+00:00,High Growth Tech Stocks To Watch In The US June 2025,Yahoo,https://finnhub.io/api/news?id=a06af45d94216e5589576e3d6c33423184f628f6ce8cd969ba9cb67f134d8590
APLS,2025-06-04T11:00:00+00:00,Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference,Yahoo,https://finnhub.io/api/news?id=a4bbcd492619b6e159aaf744019f0dfddb9f271d8677aab99f8d070e95183889
APLS,2025-06-03T06:23:32+00:00,"Why Apellis Pharmaceuticals, Inc. (APLS) Skyrocketed On Monday",Yahoo,https://finnhub.io/api/news?id=52a86801f6ade45c8dfd96e39ba5a9362c9beae5dcc59f40f34175928f6a5c68
APLS,2025-05-27T19:00:27+00:00,"Transcript : Apellis Pharmaceuticals, Inc. Presents at Stifel 2025 Virtual Ophthalmology Forum, May-27-2025 02",Finnhub,https://finnhub.io/api/news?id=3a2e00f24d22a4966b12dcb12685b0a28f4d943c1dfef31438d02d5cf0a57b94
APLS,2025-05-20T09:28:06+00:00,Apellis Pharmaceuticals: Have Some Patience,SeekingAlpha,https://finnhub.io/api/news?id=d1a69ff32abe422a5b6dbec1482bc37f97ff87e9213adb9c2a51d2b054e40ae0
APLS,2025-05-09T15:38:28+00:00,"Apellis Pharmaceuticals' Funding Gaps, Weak Syfovre Sales Cloud Outlook, BofA Says",Yahoo,https://finnhub.io/api/news?id=a9517b4fec50d37b48faf46d568785b234940f708959b6a8aa1f3840ceeba67c
APLS,2025-05-09T14:35:52+00:00,Apellis price target lowered to $20 from $28 at Scotiabank,Yahoo,https://finnhub.io/api/news?id=281d0be153fec59a80162705c7ba68523f45d954726220fad09694346ce7a344
APLS,2025-05-09T13:18:34+00:00,Apellis Pharmaceuticals downgraded by Raymond James due to ’added uncertainty’,Yahoo,https://finnhub.io/api/news?id=94846bfcd59844af6ede428484fd8e845c757838859e6388db1db02aaad6ae29
APLS,2025-05-09T12:46:27+00:00,"Is Apellis Pharmaceuticals, Inc. (APLS) The Best Stock That Will Bounce Back?",Yahoo,https://finnhub.io/api/news?id=c2560c698cd6bd42be00e464b2b95c0e3acc5a368b594f771b958e2bbc4c04ab
APLS,2025-05-08T14:43:00+00:00,"Apellis' Q1 Earnings and Revenues Miss Estimates, Stock Down",Yahoo,https://finnhub.io/api/news?id=b2084e77621a6424c3fc6183b3e15ff4909a8df24a7c339eae6389ff78ba980a
APLS,2025-05-08T07:13:30+00:00,Apellis Pharmaceuticals Inc (APLS) Q1 2025 Earnings Call Highlights: Strong Market Leadership ...,Yahoo,https://finnhub.io/api/news?id=7d291453a18a0db22856d7b571720ab9d23214a9fdc90ce7b21f9703035e05e5
APLS,2025-05-08T04:45:52+00:00,Q1 2025 Apellis Pharmaceuticals Inc Earnings Call,Yahoo,https://finnhub.io/api/news?id=ae7d799e744f1a7529a1d9e3d5c0b936fbf93770018abbfd93aeb7d90cb1b5e2
APLS,2025-05-07T22:09:10+00:00,Why Apellis Pharmaceuticals Wilted on Wednesday,Yahoo,https://finnhub.io/api/news?id=10441fb85df0c141c4864047c6855d4ccaaaa9242808e444cb7b86da2267ad90
APLS,2025-05-07T13:30:37+00:00,Apellis Pharmaceuticals (APLS) Reports Q1 Earnings: What Key Metrics Have to Say,Yahoo,https://finnhub.io/api/news?id=12d5cc344bd18fe443c4db2415a90ea5a758f5e1bf23b2190dbf68fa2767e7c7
APLS,2025-05-07T13:18:48+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Q1 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=6b0dac8b84f483754cd44c799a92c92e7d31b8b560f07a3a6ae7c47469cc9ef6
APLS,2025-05-07T13:18:27+00:00,"Apellis Pharmaceuticals, Inc. 2025 Q1 - Results - Earnings Call Presentation",SeekingAlpha,https://finnhub.io/api/news?id=3e5f6f545864bbbade2bcb6009fd9384747510b56dbba13f811600eba59fa912
APLS,2025-05-07T12:10:04+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Reports Q1 Loss, Lags Revenue Estimates",Yahoo,https://finnhub.io/api/news?id=256c72e9a83319d915d3aa8ab6a7cf6c19be3184e176d8b5142655ee672d75d0
APLS,2025-05-07T11:00:00+00:00,Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results,Yahoo,https://finnhub.io/api/news?id=081e0b18705e6c988c0cb31489214e3d039701da711b6a4460f54e9e34131117
APLS,2025-05-07T07:02:00+00:00,"Apellis Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025",Finnhub,https://finnhub.io/api/news?id=a28ddafc509224f54da7cd1314baa2aa96112730d8b2d856c969e3ba791198bd
APLS,2025-05-06T11:00:00+00:00,Apellis Pharmaceuticals to Present at Upcoming Investor Conferences,Yahoo,https://finnhub.io/api/news?id=eb2902b87dd366e7f3324e6d62347e8c52f2e1eca74b45a1803a3ca00fe1e5f2
APLS,2025-05-06T07:00:00+00:00,"Transcript : Apellis Pharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08",Finnhub,https://finnhub.io/api/news?id=9dadb17eb2faf02bafb001478719c45436975c516b65e68d1f2fe47c81a225a9
APLS,2025-05-01T17:40:40+00:00,High Growth Tech Stocks In The US For May 2025,Yahoo,https://finnhub.io/api/news?id=e856c8a2880cf061cefcdc8fc590273f7b2cee14bc4d61698211d010f3c19e98
APLS,2025-04-30T14:01:38+00:00,"Will Rhythm Pharmaceuticals, Inc. (RYTM) Report Negative Earnings Next Week? What You Should Know",Yahoo,https://finnhub.io/api/news?id=ee23aa2cedd64e2f5f4ef01b995142f0630051be2fb2d897e98d110a92f83dfd
APLS,2025-04-30T11:00:00+00:00,"Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results",Yahoo,https://finnhub.io/api/news?id=30daf40fa1f1854a3b111ce79218b700094ad9896d4cb16a65b105b7a39529dd
APLS,2025-04-30T07:00:00+00:00,"Transcript : Apellis Pharmaceuticals, Inc., Q1 2025 Earnings Call, May 07, 2025",Finnhub,https://finnhub.io/api/news?id=e97b9b8571736b63a31c558c666b2f1df24c44d9dae982ad80a53ee7dc9ccd3e
APLS,2025-04-30T00:24:40+00:00,"Is Apellis Pharmaceuticals, Inc. (APLS) the Best Oversold NASDAQ Stock to Buy Right Now?",Yahoo,https://finnhub.io/api/news?id=a2b2de4b1ae507b3edfb8c4d0e12fd6f20eaa81530db040b6a39926107017e0f
APLS,2025-04-29T14:01:23+00:00,"Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release",Yahoo,https://finnhub.io/api/news?id=79849126da00bcba178a034c5e3fd0ea061f26cc0f2d83987cda123964ce3f8f
APLS,2025-04-23T16:56:33+00:00,"Is Apellis Pharmaceuticals, Inc. (APLS) Among the Best Guru Stocks to Buy According to Wall Street Analysts?",Yahoo,https://finnhub.io/api/news?id=b1c20054ea4cca314bad2afc89584505cb009ca8a2dd6c3207e32cb6aa342389
APLS,2025-04-21T11:00:00+00:00,Apellis Announces Craig Wheeler to Join the Board of Directors,Yahoo,https://finnhub.io/api/news?id=875be2675f9236a17a9845692acf28dc2b57f5059cf80dd3faa404c45a6c2a76
APLS,2025-04-15T11:20:00+00:00,BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock?,Yahoo,https://finnhub.io/api/news?id=3cbf8e2a02903b878282baededf36835d3995865303aef472e7894f2aa921831
APLS,2025-04-02T13:11:00+00:00,APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag,Yahoo,https://finnhub.io/api/news?id=42d662dbe5123bfe0ddc209796649300b5fe51ed1a73c014d4ed23413b6b9148
APLS,2025-04-02T08:55:43+00:00,FDA accepts priority review of Apellis’ Empaveli sNDA for kidney diseases,Yahoo,https://finnhub.io/api/news?id=3c0d97955f9b26ec60f52744609ef3919320a7076ecbca36c37caefe4966d4a0
APLS,2025-04-01T11:00:00+00:00,Apellis Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN,Yahoo,https://finnhub.io/api/news?id=e2497a17796e0e63c0fa5ce1ac2e2db97bd6a1a5dbd6ccab2c2a8b605b0f5c12
APLS,2025-03-31T17:08:11+00:00,Exploring US High Growth Tech Stocks In March 2025,Yahoo,https://finnhub.io/api/news?id=76294909dbf910f6840e0cbad29ffa431914cd26b5b4cb213a0e3c171f99ab21
APLS,2025-03-30T03:50:00+00:00,abrdn Life Sciences Investors Q4 2024 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=66dc9f2b53ce613484d516524a22eafdccbe115cabd59877c7d52f9cd1ad811b
APLS,2025-03-25T21:41:24+00:00,"Is Apellis Pharmaceuticals, Inc. (APLS) a Promising Biotech Stock According to Wall Street Analysts",Yahoo,https://finnhub.io/api/news?id=5c4827f740fa0a840bb28c8dddd1ae32c16691fb1744ce6f905ac131a1caee6f
APLS,2025-03-22T15:41:02+00:00,Morgan Stanley says Fabhalta’s label leaves opportunity for Apellis’ Empaveli,Yahoo,https://finnhub.io/api/news?id=dc0dcdaa28bd8c11f3922865f982350c554e3eb211d3336b6a97aa90e07faec6
APLS,2025-03-21T13:13:44+00:00,Upgrading Beam Therapeutics: Promising BEAM-302 Data Opens Door For Durable Gene Therapy,SeekingAlpha,https://finnhub.io/api/news?id=7c70894f08e5837301f73fda59cdf2c82427429322b85a54b41d03ba7f981381
APLS,2025-03-05T19:04:46+00:00,Apellis Lead Drug Pegcetacoplan Represents Differentiated Asset: JP Morgan Analyst,Yahoo,https://finnhub.io/api/news?id=812a42ba297c68d20d3049baa281e4d95f14acff2e56b7c7ee0261cfe78c98b1
APLS,2025-03-05T14:06:03+00:00,Apellis Pharmaceuticals: A Mixed Bag,SeekingAlpha,https://finnhub.io/api/news?id=5e7ca9db87eb0624f7186843676e3e9b2ce035e0de99c1d2a33124a7abeae1d3
APLS,2025-03-03T15:56:00+00:00,"Apellis Q4 Loss Narrower Than Expected, Syfovre Sales Drive Revenues",Yahoo,https://finnhub.io/api/news?id=3705b9d98e65808140130680be420894cbfcda938940fcb7d67b9c021c4a0abd
APLS,2025-03-02T02:08:44+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Q4 2024 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=d4948d7aa398670fec0d7b5d91f891a723bb5b9330c16a95bc2c29ee0e9bb339
APLS,2025-03-02T00:03:10+00:00,"Apellis Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation",SeekingAlpha,https://finnhub.io/api/news?id=33e06bda781fe6eb967133ed4b70ed72e6d0157e38bcbf9824f78455fb86634c
APLS,2025-03-01T12:48:50+00:00,Apellis Pharmaceuticals Full Year 2024 Earnings: Beats Expectations,Yahoo,https://finnhub.io/api/news?id=6ac2e317443095fdbc9ebf017acc2764c0ec3503ab2ea2392df92f787e5aab2b
APLS,2025-03-01T07:08:13+00:00,Apellis Pharmaceuticals Inc (APLS) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and ...,Yahoo,https://finnhub.io/api/news?id=091d4a330b592bbd1e49070a472514dc4a9996f7793de4815cbdcacbc06b581e
APLS,2025-03-01T06:29:22+00:00,Q4 2024 Apellis Pharmaceuticals Inc Earnings Call,Yahoo,https://finnhub.io/api/news?id=72aeb1132d4ce0e5914235de7a36cbc9ebb834ceb0aa3e8435f108ed315c2a5a
APLS,2025-02-28T14:30:14+00:00,"Compared to Estimates, Apellis Pharmaceuticals (APLS) Q4 Earnings: A Look at Key Metrics",Yahoo,https://finnhub.io/api/news?id=12130027f578dfe2619d150c9492b1c16368eeb9d74f325465d4697cbcaf788f
APLS,2025-02-28T13:15:02+00:00,"Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Tops Revenue Estimates",Yahoo,https://finnhub.io/api/news?id=ed4920fb7ebc48e3cea80837362c0a7aa1b780cad9377ebda5cb9f48380be27e
APLS,2025-02-28T12:05:00+00:00,Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results,Yahoo,https://finnhub.io/api/news?id=58b68ab1187645f62366a20a19796ff797323f1957934fb002354da76e1ace68
APLS,2025-02-25T15:00:10+00:00,"Y-mAbs Therapeutics, Inc. (YMAB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release",Yahoo,https://finnhub.io/api/news?id=3316566170f9e663fa5044af94ebdca4a75f10ff97191a8614289d5d7e75ada1
APLS,2025-02-24T12:00:00+00:00,Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference,Yahoo,https://finnhub.io/api/news?id=3d887a38251e9625b2ca6854b94c06ec715e731b0cd6d7937a212504cdff82d0
APLS,2025-02-23T18:31:00+00:00,"Why Apellis Pharmaceuticals, Inc. (APLS) is the Most Oversold Pharma Stock to Buy According to Analysts",Yahoo,https://finnhub.io/api/news?id=b34ddf91447f2c5407987e121656e8d52f02339f7e74089bb92a3ee0eae8f972
APLS,2025-02-21T15:00:07+00:00,"Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release",Yahoo,https://finnhub.io/api/news?id=4811adb9739526f243c611c4d21e5d763aaccd9f2f06081a3ca741065732a9e6
APLS,2025-02-21T14:02:13+00:00,High Growth Tech Stocks In The United States To Watch,Yahoo,https://finnhub.io/api/news?id=dedc2a3bde6b22be51688a8d694265f5ed1e8a597eff0e03b9ad0d55809dc632
APLS,2025-02-20T17:08:25+00:00,Is Apellis Pharmaceuticals (APLS) One of the Most Oversold Healthcare Stocks to Buy Now?,Yahoo,https://finnhub.io/api/news?id=c9ad5b51265f440ba34f2d2e6b671ce7c08e000f41bb1f402f905d7d1b6044d0
APLS,2025-02-20T07:00:00+00:00,Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN,Yahoo,https://finnhub.io/api/news?id=46b4d6e26415d4fdce5e5be5231b63e736c8059afcd72bfc2ff85fc04276e528
APLS,2025-02-18T21:12:57+00:00,Apellis Pharmaceuticals (APLS): Among Top Insider Stock Buys And Sells In January,Yahoo,https://finnhub.io/api/news?id=82ec5da168dd07aade04dc20a96c41d2265743a87652ef9e9344418fc7853a4e
APLS,2025-02-14T12:00:00+00:00,"Apellis Pharmaceuticals to Host Conference Call on February 28, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results",Yahoo,https://finnhub.io/api/news?id=ea4337ca005fa656899a9b8588454dfee552206ed32b278dcbf938f629460f53
APLS,2025-02-13T10:32:12+00:00,Apellis Pharmaceuticals (NASDAQ:APLS investor one-year losses grow to 58% as the stock sheds US$231m this past week,Yahoo,https://finnhub.io/api/news?id=d4697c909342d6c78e21189e135bd07c189700acdb6ed7e5d782f6388ad96e4e
APLS,2025-02-11T19:03:05+00:00,"Why Insiders Are Selling Apellis Pharmaceuticals, Inc. (APLS) Recently",Yahoo,https://finnhub.io/api/news?id=b6e098e6caa0ba8215da918fae728e1fce65432fed14eb2cd83f0cdf7ba15f3c
APLS,2025-02-05T18:28:30+00:00,Belite Bio: The Picture Is Still Unclear,SeekingAlpha,https://finnhub.io/api/news?id=59c9af07cdd49552f7b19a9715db822434f608fbf2f794243495339d2ef333ea
APLS,2025-01-27T16:01:03+00:00,Apellis Receives Approval of SYFOVRE® (pegcetacoplan) in Australia for Geographic Atrophy (GA),Finnhub,https://finnhub.io/api/news?id=a2b16e18f209e956b0d2e0c0ed6f326b1129e63d3a6ec936593eb8065f9c6e55
APLS,2025-01-13T10:03:19+00:00,Apellis Announces Keli Walbert to Join the Board of Directors,Finnhub,https://finnhub.io/api/news?id=a61ca9cdb1d6bc8b29491313013196df489bcde76e96b6d6458c47d9d8691312
APLS,2025-01-13T09:02:03+00:00,Apellis Highlights Commercial Growth and Strategic Priorities at 43rd Annual J.P. Morgan Healthcare Conference,Finnhub,https://finnhub.io/api/news?id=00f5ccd15f7adcce3b8b2d94c153e43bda37ee574c9ded044d4e621c282c9715
APLS,2025-01-08T09:55:49+00:00,Apellis Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4),Finnhub,https://finnhub.io/api/news?id=b0a2e1a9f93c7e88cf04f5f977895983ba87f69fa55d51520651efda8b4baf9e
APLS,2025-01-07T21:05:00+00:00,Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Yahoo,https://finnhub.io/api/news?id=9b15ee9985ad9a5be396ed285a6f6b15782c6712f801cbc45d6e7d58b70ffe0f
APLS,2025-01-06T12:00:00+00:00,Apellis Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference,Yahoo,https://finnhub.io/api/news?id=3729cf5638948e70d54936ab06864499df5d247f52a13306fcf3c27fe4d2683b
APLS,2025-01-03T18:02:45+00:00,Exploring 3 High Growth Tech Stocks In The United States,Yahoo,https://finnhub.io/api/news?id=bf4a169395a68e6ab1151bdf4796efaccb7897303c00e9e80e5432fe20620b02
APLS,2024-12-25T03:07:03+00:00,Apellis: Saved By The October Data,SeekingAlpha,https://finnhub.io/api/news?id=1ad2bd3769b7f440d3236684bb79b9e20f436031c4d668748701a859cf36890b
APLS,2024-12-12T16:30:29+00:00,Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue?,Yahoo,https://finnhub.io/api/news?id=ca526520a0935fb6b04884d13162bb9c4844cc2830cdd458a3b60f2fa135439a
APLS,2024-12-12T14:35:48+00:00,Should You Hold Apellis Pharmaceuticals (APLS)?,Yahoo,https://finnhub.io/api/news?id=3f0a93ba0f5ce92d487038f9d6eeb279947fce61c873fe275858f193373be36b
APLS,2024-12-10T02:30:00+00:00,Columbia Small Cap Value Fund II Q3 2024 Commentary,SeekingAlpha,https://finnhub.io/api/news?id=f41143609aa079adaad4099ff9c14ad29a8d23c692b6aff79a29fdbec96950f0
APLS,2024-12-06T16:31:17+00:00,Why Is Amicus Therapeutics (FOLD) Down 11.1% Since Last Earnings Report?,Yahoo,https://finnhub.io/api/news?id=59fda6d0d650f4178c7a654bb5ce2b2c1bccb047e4f1e145d28f2047d8dca231
APLS,2024-12-05T16:30:44+00:00,Why Is Apellis Pharmaceuticals (APLS) Up 18.4% Since Last Earnings Report?,Yahoo,https://finnhub.io/api/news?id=7b47488b7ea8335fd27a90e6a855990c7fef03c68b1ad17f71b98f3c736c6e35
APLS,2024-12-04T14:07:50+00:00,Exploring Three High Growth Tech Stocks in the United States,Yahoo,https://finnhub.io/api/news?id=2c11b9176ba01d95a31f820a836ab7d1c6b78c4824727c5b706a66c4d8b74e3b
